Wa’ed Ventures leads pre-Series A funding for US biotech firm Kure Cells
The round saw participation from Kingdom’s Qomel Company, US-based NantBio, and US93
Available in your choice of English or Arabic
The round saw participation from Kingdom’s Qomel Company, US-based NantBio, and US93
The strategy expects to net SAR 130 bn for non-oil GDP by 2040
Queue